DK0516941T3 - Pyrazolopyridinforbindelser og fremgangsmåder til fremstilling deraf - Google Patents
Pyrazolopyridinforbindelser og fremgangsmåder til fremstilling derafInfo
- Publication number
- DK0516941T3 DK0516941T3 DK92106028.1T DK92106028T DK0516941T3 DK 0516941 T3 DK0516941 T3 DK 0516941T3 DK 92106028 T DK92106028 T DK 92106028T DK 0516941 T3 DK0516941 T3 DK 0516941T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- methods
- pyrazolopyridine compounds
- pharmaceutically acceptable
- pyrazolopyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Position Input By Displaying (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919107513A GB9107513D0 (en) | 1991-04-10 | 1991-04-10 | Pyrazolopyridine compound and processes for preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0516941T3 true DK0516941T3 (da) | 1997-01-06 |
Family
ID=10692949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92106028.1T DK0516941T3 (da) | 1991-04-10 | 1992-04-08 | Pyrazolopyridinforbindelser og fremgangsmåder til fremstilling deraf |
Country Status (23)
Country | Link |
---|---|
US (1) | US5234930A (ko) |
EP (1) | EP0516941B1 (ko) |
JP (2) | JP2546470B2 (ko) |
KR (1) | KR100248700B1 (ko) |
CN (2) | CN100508975C (ko) |
AT (1) | ATE146473T1 (ko) |
AU (1) | AU653007B2 (ko) |
CA (1) | CA2065644C (ko) |
DE (1) | DE69215965T2 (ko) |
DK (1) | DK0516941T3 (ko) |
ES (1) | ES2095976T3 (ko) |
FI (1) | FI100969B (ko) |
GB (1) | GB9107513D0 (ko) |
GR (1) | GR3022113T3 (ko) |
HU (2) | HU214871B (ko) |
IE (1) | IE921086A1 (ko) |
IL (1) | IL101544A (ko) |
MX (1) | MX9201672A (ko) |
NO (1) | NO300271B1 (ko) |
RU (1) | RU2069662C1 (ko) |
SG (1) | SG43917A1 (ko) |
TW (1) | TW205550B (ko) |
UA (1) | UA27252C2 (ko) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5541213A (en) * | 1993-06-24 | 1996-07-30 | Eisai Co., Ltd. | Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility |
EP0737193A1 (en) * | 1993-12-29 | 1996-10-16 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine adenosine antagonists |
EP0900796B1 (en) * | 1996-04-25 | 2004-12-15 | Fujisawa Pharmaceutical Co., Ltd. | Preventives and remedies for ischemic intestinal lesion and ileus |
AUPO111096A0 (en) * | 1996-07-18 | 1996-08-08 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
US6303624B1 (en) | 1997-03-18 | 2001-10-16 | Fujisawa Pharmaceutical Co., Ltd. | Preventives and remedies for hyperphosphatemia |
CA2333947C (en) * | 1998-06-01 | 2010-09-21 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compounds as adenosine a1 antagonist for male sterility |
US20040152659A1 (en) * | 1999-05-12 | 2004-08-05 | Fujisawa Pharmaceutical Co. Ltd. | Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist |
PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
EP1377573B1 (en) * | 2000-12-15 | 2005-07-27 | Glaxo Group Limited | Pyrazolopyridine derivatives |
AU2002239344A1 (en) * | 2000-12-15 | 2002-06-24 | Glaxo Group Limited | Pyrazolopyridines |
US7153855B2 (en) * | 2001-03-08 | 2006-12-26 | Smithkline Beecham Corporation | Pyrazolopyridinyl pyrimidine therapeutic compounds |
JP4237497B2 (ja) * | 2001-03-30 | 2009-03-11 | スミスクライン ビーチャム コーポレーション | ピラゾロピリジン類、その調製方法及びその治療用化合物としての使用 |
JP2004525150A (ja) * | 2001-03-30 | 2004-08-19 | スミスクライン ビーチャム コーポレーション | 治療用化合物としてのピラゾロピリジン類の使用 |
WO2002083672A1 (en) * | 2001-04-10 | 2002-10-24 | Smithkline Beecham Corporation | Antiviral pyrazolopyridine compounds |
WO2002088124A2 (en) * | 2001-04-27 | 2002-11-07 | Smithkline Beecham Corporation | Pyrazolo'1,5-a!pyridine derivatives |
AUPR548601A0 (en) * | 2001-06-06 | 2001-06-28 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyrazinecompound and pharmaceutical use thereof |
JP2005500315A (ja) * | 2001-06-21 | 2005-01-06 | スミスクライン ビーチャム コーポレーション | ヘルペスウイルス感染の予防および治療用イミダゾ[1,2−a]ピリジン誘導体 |
ATE364043T1 (de) * | 2001-09-07 | 2007-06-15 | Smithkline Beecham Corp | Pyrazolo-pyridine für die behandlung von herpes- ansteckungen |
ES2262893T3 (es) * | 2001-10-05 | 2006-12-01 | Smithkline Beecham Corporation | Derivados de imidazo-piridina para su uso en el tratamiento de infeccion virica por herpes. |
WO2003050120A1 (en) * | 2001-12-11 | 2003-06-19 | Smithkline Beecham Corporation | Pyrazolo-pyridine derivatives as antiherpes agents |
WO2004033454A1 (en) * | 2002-10-03 | 2004-04-22 | Smithkline Beecham Corporation | Therapeutic compounds based on pyrazolopyridine derivatives |
JP5352452B2 (ja) * | 2006-06-06 | 2013-11-27 | メディシノバ, インコーポレイテッド | 置換ピラゾロ[1,5−a]ピリジン化合物およびその使用方法 |
US9572528B1 (en) | 2012-08-06 | 2017-02-21 | Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center | Monitor for SIDS research and prevention |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925849A (en) * | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines |
GB8901423D0 (en) * | 1989-01-23 | 1989-03-15 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
-
1991
- 1991-04-10 GB GB919107513A patent/GB9107513D0/en active Pending
-
1992
- 1992-04-02 AU AU13988/92A patent/AU653007B2/en not_active Expired
- 1992-04-02 TW TW081102547A patent/TW205550B/zh active
- 1992-04-03 IE IE108692A patent/IE921086A1/en not_active IP Right Cessation
- 1992-04-07 FI FI921522A patent/FI100969B/fi not_active IP Right Cessation
- 1992-04-08 SG SG1996005302A patent/SG43917A1/en unknown
- 1992-04-08 DE DE69215965T patent/DE69215965T2/de not_active Expired - Lifetime
- 1992-04-08 AT AT92106028T patent/ATE146473T1/de active
- 1992-04-08 ES ES92106028T patent/ES2095976T3/es not_active Expired - Lifetime
- 1992-04-08 EP EP92106028A patent/EP0516941B1/en not_active Expired - Lifetime
- 1992-04-08 DK DK92106028.1T patent/DK0516941T3/da active
- 1992-04-09 CA CA002065644A patent/CA2065644C/en not_active Expired - Lifetime
- 1992-04-09 KR KR1019920005893A patent/KR100248700B1/ko not_active IP Right Cessation
- 1992-04-09 CN CNB971253781A patent/CN100508975C/zh not_active Expired - Lifetime
- 1992-04-09 RU SU5011507/04A patent/RU2069662C1/ru active
- 1992-04-09 HU HU9201213A patent/HU214871B/hu unknown
- 1992-04-09 NO NO19921413A patent/NO300271B1/no not_active IP Right Cessation
- 1992-04-09 JP JP4088735A patent/JP2546470B2/ja not_active Expired - Lifetime
- 1992-04-09 CN CN92103372A patent/CN1041203C/zh not_active Expired - Lifetime
- 1992-04-09 US US07/866,215 patent/US5234930A/en not_active Expired - Lifetime
- 1992-04-09 IL IL10154492A patent/IL101544A/en not_active IP Right Cessation
- 1992-04-10 MX MX9201672A patent/MX9201672A/es unknown
-
1993
- 1993-06-18 UA UA93002532A patent/UA27252C2/uk unknown
-
1995
- 1995-06-22 HU HU95P/P00354P patent/HU211680A9/hu unknown
- 1995-11-16 JP JP7298193A patent/JP2903040B2/ja not_active Expired - Fee Related
-
1996
- 1996-12-19 GR GR960403475T patent/GR3022113T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0516941T3 (da) | Pyrazolopyridinforbindelser og fremgangsmåder til fremstilling deraf | |
DK0379979T3 (ko) | ||
DK0467248T3 (da) | Pyrazolopyridinforbindelse og fremgangsmåder til fremstilling heraf | |
MX9306831A (es) | Nuevos compuestos heterociclicos. | |
DK0412404T3 (da) | Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne | |
FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
OA09039A (fr) | Acides 3-alcenyl-1-azabicyclo(3.2.0)hep-2-ene-2carboxyliques | |
DK491489D0 (da) | Imidazolinderivater samt fremgangsmaade til fremstilling deraf | |
ATE84035T1 (de) | Antivirale tetrahydroimidazo(1,4)benzodiazepin-2- one. | |
HU9203849D0 (en) | Thiazole derivatives | |
FI895139A0 (fi) | Pyrrolidinderivat. | |
ES2061579T3 (es) | Compuestos cefem y procedimientos para su preparacion. | |
EP0452809A3 (en) | A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives |